The 4 Pillars of a Successful Cell and Gene Therapy Launch
As part of our ongoing commitment to developing and supporting commercialization strategies for Cell and Gene Therapy (CGT) products, Archbow has been actively involved with the Bio Supply Management Alliance (BSMA.)
At the BSMA annual meeting, Kevin Cast and Paul Furgal sat down with Devendra Mishra, Executive Director of BSMA, for an interview on what it takes to successfully launch a CGT product in today's marketplace.
To learn more about the four pillars of a successful CGT launch and how traditional pharmaceutical distribution must be transformed to meet the challenges of these revolutionary therapies, read the full Q&A here.
If you're preparing to launch a CGT product and would like to tap into the resources and expertise Archbow Consulting has to offer, contact us today.
Related Resource: Cell and Gene Therapy Supply Chain Case Study - learn how a U.S. biotech company established a global supply chain for a cell therapy with complicated and unique characteristics.
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn, Twitter or subscribing to this blog which you can do below.